CD274 and inflammatory bowel disease: We used a common murine model of chronic IBD that involved rectal administration of TNBS [14, 28, 29], and we administered a PD-1 inhibitor, or 5-ASA as a positive control, to determine the pathogenic association of the PD-1/PD-L1 pathway with IBD.